Research location
Rostock
Germany
Advertisement
Research activity in Rostock
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 252 trials and 285 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Rostock
252 linked trials · page 2 of 6Study of Evobrutinib in Participants With RMS (evolutionRMS 2)NCT04338061 · 2020-07-02 · 1 site observation
TERMINATED
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)NCT04410978 · 2020-06-30 · 1 site observation
COMPLETED
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice (SURE GERMANY)NCT04261933 · 2020-02-13 · 1 site observation
COMPLETED
Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild ADNCT04191486 · 2019-12-24 · 1 site observation
COMPLETED
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast CancerNCT04109066 · 2019-11-18 · 1 site observation
COMPLETED
Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life ConditionsNCT04184284 · 2019-11-15 · 1 site observation
COMPLETED
Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)NCT03961204 · 2019-08-15 · 1 site observation
COMPLETED
A Study in Parkinson's Disease in Patients With Moderate to Severe DyskinesiaNCT03956979 · 2019-07-22 · 1 site observation
COMPLETED
Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus ChemotherapyNCT03911219 · 2019-07-10 · 2 site observations
COMPLETED
Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)NCT03954132 · 2019-06-07 · 1 site observation
COMPLETED
COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart FailureNCT03917459 · 2019-04-16 · 1 site observation
COMPLETED
Safety and Performance Aspects of CRT-DX System in Patients With Sinus RhythmNCT03839121 · 2019-04-01 · 1 site observation
COMPLETED
Reducing Lung CongestIon Symptoms in Advanced Heart FailureNCT03499236 · 2018-09-19 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor TherapyNCT03584009 · 2018-09-06 · 1 site observation
TERMINATED
Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart FailureNCT03494933 · 2018-09-01 · 1 site observation
TERMINATED
Patient Preference for Pegfilgrastim (Neulasta®) Application FormsNCT03619993 · 2018-06-25 · 1 site observation
COMPLETED
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])NCT03517449 · 2018-06-11 · 1 site observation
COMPLETED
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)NCT03444870 · 2018-06-06 · 1 site observation
TERMINATED
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate CancerNCT03511664 · 2018-05-29 · 1 site observation
COMPLETED
Participant-Reported Outcomes With the Accu-Chek® Solo Micropump SystemNCT03478969 · 2018-05-17 · 1 site observation
COMPLETED
To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.NCT03286842 · 2018-01-17 · 1 site observation
COMPLETED
A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast CancerNCT03337724 · 2018-01-06 · 1 site observation
COMPLETED
Investigation of a Novel Integrated Care Concept (NICC) for Patients Suffering From Chronic Cardiovascular DiseaseNCT03317951 · 2017-12-01 · 1 site observation
UNKNOWN
Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid ArthritisNCT03387423 · 2017-11-02 · 1 site observation
COMPLETED
SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After ProstatectomyNCT02945813 · 2017-10-24 · 1 site observation
TERMINATED
The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure PatientsNCT03030274 · 2017-10-11 · 1 site observation
COMPLETED
A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line TreatmentNCT06311383 · 2017-10-09 · 1 site observation
COMPLETED
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF PatientsNCT03066804 · 2017-08-22 · 1 site observation
COMPLETED
Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)NCT03165045 · 2017-05-26 · 1 site observation
COMPLETED
A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)NCT02985957 · 2017-03-26 · 1 site observation
COMPLETED
A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaNCT03052725 · 2017-03-10 · 1 site observation
TERMINATED
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & MortalityNCT03036462 · 2017-03-07 · 1 site observation
COMPLETED
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or FulvestrantNCT02894398 · 2016-09-06 · 1 site observation
COMPLETED
Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology PracticeNCT02847728 · 2016-07-28 · 2 site observations
COMPLETED
Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 DiabetesNCT02825251 · 2016-07-06 · 1 site observation
COMPLETED
STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience ProgramNCT02825264 · 2016-07-01 · 1 site observation
ACTIVE_NOT_RECRUITING
PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLCNCT02777658 · 2016-05-26 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).NCT02670083 · 2016-03-22 · 1 site observation
TERMINATED
TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABANCT02676076 · 2016-02-17 · 1 site observation
COMPLETED
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's DiseaseNCT02655315 · 2016-02-09 · 1 site observation
COMPLETED
Efficacy and Safety Study of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.NCT02555683 · 2015-12-11 · 1 site observation
COMPLETED
Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted AgentNCT02485691 · 2015-11-09 · 1 site observation
COMPLETED
An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood EosinophilsNCT02501629 · 2015-09-29 · 1 site observation
COMPLETED
European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)NCT02495974 · 2015-09-08 · 1 site observation
COMPLETED
Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®NCT02499900 · 2015-08-10 · 1 site observation
COMPLETED
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.NCT02437318 · 2015-07-23 · 1 site observation
COMPLETED
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.NCT02486302 · 2015-03-24 · 3 site observations
COMPLETED
Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's DiseaseNCT02389413 · 2015-03-01 · 1 site observation
COMPLETED
A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to PlaceboNCT02284568 · 2015-01-12 · 1 site observation
COMPLETED
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409NCT02255656 · 2015-01-07 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.